Lindbrook Capital’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $16.5K | Sell |
2,076
-1,578
| -43% | -$12.6K | ﹤0.01% | 1437 |
|
2024
Q4 | $33.2K | Buy |
3,654
+1,612
| +79% | +$14.7K | ﹤0.01% | 993 |
|
2024
Q3 | $18.7K | Buy |
2,042
+793
| +63% | +$7.28K | ﹤0.01% | 1335 |
|
2024
Q2 | $12.2K | Buy |
1,249
+1,145
| +1,101% | +$11.2K | ﹤0.01% | 1517 |
|
2024
Q1 | $1.57K | Sell |
104
-412
| -80% | -$6.22K | ﹤0.01% | 2317 |
|
2023
Q4 | $11.1K | Sell |
516
-740
| -59% | -$15.9K | ﹤0.01% | 1494 |
|
2023
Q3 | $23.3K | Buy |
1,256
+5
| +0.4% | +$93 | ﹤0.01% | 999 |
|
2023
Q2 | $31.7K | Sell |
1,251
-261
| -17% | -$6.61K | ﹤0.01% | 879 |
|
2023
Q1 | $39.2K | Sell |
1,512
-2,143
| -59% | -$55.5K | ﹤0.01% | 785 |
|
2022
Q4 | $86.4K | Buy |
3,655
+381
| +12% | +$9.01K | 0.01% | 526 |
|
2022
Q3 | $83K | Buy |
3,274
+13
| +0.4% | +$330 | 0.01% | 498 |
|
2022
Q2 | $108K | Buy |
3,261
+1,620
| +99% | +$53.7K | 0.02% | 429 |
|
2022
Q1 | $118K | Buy |
1,641
+146
| +10% | +$10.5K | 0.02% | 415 |
|
2021
Q4 | $137K | Sell |
1,495
-9
| -0.6% | -$825 | 0.02% | 409 |
|
2021
Q3 | $191K | Sell |
1,504
-10
| -0.7% | -$1.27K | 0.05% | 153 |
|
2021
Q2 | $252K | Sell |
1,514
-90
| -6% | -$15K | 0.06% | 139 |
|
2021
Q1 | $292K | Sell |
1,604
-13
| -0.8% | -$2.37K | 0.07% | 120 |
|
2020
Q4 | $323K | Buy |
1,617
+93
| +6% | +$18.6K | 0.08% | 99 |
|
2020
Q3 | $334K | Buy |
1,524
+16
| +1% | +$3.51K | 0.09% | 88 |
|
2020
Q2 | $288K | Sell |
1,508
-203
| -12% | -$38.8K | 0.09% | 97 |
|
2020
Q1 | $265K | Buy |
+1,711
| New | +$265K | 0.1% | 85 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 1557 |
|